DUBLIN--(BUSINESS WIRE)--The "Ulcerative Colitis Forecast in 12 Major Markets 2017-2027" report has been added to Research and Markets' offering.
This report provides the current prevalent population for Ulcerative Colitis across 12 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Russia, Brazil, Japan, China, India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight, several of the main symptoms and co-morbidities of Ulcerative Colitis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Main symptoms and co-morbidities for Ulcerative Colitis include:
- Anaemia
- Gastritis
- Colorectal cancer
- Osteoporosis
- Complications from surgery
- Pouchitis
- Toxic megacolon
-
Extra-intestinal features (e.g. primary sclerosing cholangitis,
erythema nodosum)
Key Topics Covered:
- Introduction
- Cause of the Disease
- Risk Factors & Prevention
- Diagnosis of the Disease
- Variation by Geography/Ethnicity
- Disease Prognosis & Clinical Course
- Key Comorbid Conditions / Features Associated With the Disease
- Methodology for Quantification of Patient Numbers
- Top-Line Prevalence for Ulcerative Colitis
- Features of Ulcerative Colitis Patients
- Associated Conditions of Ulcerative Colitis
- Abbreviations Used in the Report
- Other Publications
- Online Patient-Based Databases
- Patient-Based Offering
- Online Pricing Data & Platforms
- References
-
Appendix
For more information about this report visit https://www.researchandmarkets.com/research/2g29rd/ulcerative
